Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Tugba Mutu Pek, Esra Yazici, Derya Guzel, Elif Kose, Ahmet Bülent Yazıcı & Atila Erol. (2019) The relationship between oxytocin, vasopressin and atrial natriuretic peptide levels and cognitive functions in patients with schizophrenia. Psychiatry and Clinical Psychopharmacology 29:4, pages 798-810.
Read now
Read now
Owais Gul, Saqib Gul & Abdul Aziz Godil. (2018) Posterior pituitary neurohormonal disturbances in schizophrenia and role of oxytocin in treatment – need for more short- and long-term studies. Neuropsychiatric Disease and Treatment 14, pages 2579-2582.
Read now
Read now
Articles from other publishers (12)
Danae Papadea, Christina Dalla & Despina A. Tata. (2023) Exploring a Possible Interplay between Schizophrenia, Oxytocin, and Estrogens: A Narrative Review. Brain Sciences 13:3, pages 461.
Crossref
Crossref
Adriana Colar Ferreira & Flávia de Lima Osório. (2022) Peripheral oxytocin concentrations in psychiatric disorders – A systematic review and methanalysis: Further evidence. Progress in Neuro-Psychopharmacology and Biological Psychiatry 117, pages 110561.
Crossref
Crossref
Bernard Crespi, Tanya Procyshyn & Mika Mokkonen. (2022) Natura Non Facit Saltus: The Adaptive Significance of Arginine Vasopressin in Human Affect, Cognition, and Behavior. Frontiers in Behavioral Neuroscience 16.
Crossref
Crossref
Ewa Szczepanska-Sadowska, Agnieszka Wsol, Agnieszka Cudnoch-Jedrzejewska, Katarzyna Czarzasta & Tymoteusz Żera. (2022) Multiple Aspects of Inappropriate Action of Renin–Angiotensin, Vasopressin, and Oxytocin Systems in Neuropsychiatric and Neurodegenerative Diseases. Journal of Clinical Medicine 11:4, pages 908.
Crossref
Crossref
Marta Broniarczyk-Czarniak, Janusz Szemraj, Janusz Śmigielski & Piotr Gałecki. (2022) The Role of OXT, OXTR, AVP, and AVPR1a Gene Expression in the Course of Schizophrenia. Current Issues in Molecular Biology 44:1, pages 336-349.
Crossref
Crossref
João Victor Nani, Priscila G.C. Almeida & Mirian A.F. Hayashi. 2022. Encyclopedia of Behavioral Neuroscience, 2nd edition. Encyclopedia of Behavioral Neuroscience, 2nd edition
283
292
.
Yazmín Hernández-Díaz, Thelma Beatriz González-Castro, Carlos Alfonso Tovilla-Zárate, María Lilia López-Narváez, Alma Delia Genis-Mendoza, Rosa Giannina Castillo-Avila, Miguel Ángel Ramos-Méndez & Isela Esther Juárez-Rojop. (2021) Oxytocin levels in individuals with schizophrenia are high in cerebrospinal fluid but low in serum: A systematic review and meta-analysis. Metabolic Brain Disease 36:8, pages 2415-2424.
Crossref
Crossref
Kah Kheng Goh, Chun-Hsin Chen & Hsien-Yuan Lane. (2021) Oxytocin in Schizophrenia: Pathophysiology and Implications for Future Treatment. International Journal of Molecular Sciences 22:4, pages 2146.
Crossref
Crossref
Yorick Janssens, Evelien Wynendaele, Kurt Audenaert & Bart De Spiegeleer. 2021. Biologically Active Peptides. Biologically Active Peptides
689
721
.
Donatella Marazziti, Filippo Maria Barberi, Federico Mucci, Alessandra Maglio, Valerio Dell’Oste & Liliana Dell’Osso. (2020) The Emerging Role of Atrial Natriuretic Peptide in Psychiatry. Current Medicinal Chemistry 28:1, pages 69-79.
Crossref
Crossref
Benjamín Rodríguez, João Victor Nani, Priscila G.C. Almeida, Elisa Brietzke, Richard S. Lee & Mirian A.F. Hayashi. (2020) Neuropeptides and oligopeptidases in schizophrenia. Neuroscience & Biobehavioral Reviews 108, pages 679-693.
Crossref
Crossref
Johannes R. Busch, Christina Jacobsen, Niels Lynnerup, Jytte Banner & Morten Møller. (2019) Expression of vasopressin mRNA in the hypothalamus of individuals with a diagnosis of schizophrenia. Brain and Behavior 9:9.
Crossref
Crossref